- Investing Ideas
- /
- Household Healthcare Sector
Household Healthcare Sector
Results
2306
All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.
2,306 companies
Orchestra BioMed Holdings
Market Cap: US$111.9m
Operates as a biomedical company.
OBIO
US$2.95
7D
0.3%
1Y
-42.5%
Neumora Therapeutics
Market Cap: US$111.7m
A clinical-stage biopharmaceutical company, engages in developing therapeutic treatments for brain diseases, neuropsychiatric disorders, and neurodegenerative diseases in the United States.
NMRA
US$0.73
7D
7.4%
1Y
-92.3%
Sagimet Biosciences
Market Cap: US$110.4m
A clinical-stage biopharmaceutical company, develops novel therapeutics called fatty acid synthase (FASN) inhibitors for the treatment of diseases that result from dysfunctional metabolic pathways in the United States.
SGMT
US$3.43
7D
7.9%
1Y
-28.4%
Instil Bio
Market Cap: US$110.3m
A clinical-stage biopharmaceutical company, focuses on developing a pipeline of novel therapies.
TIL
US$16.44
7D
29.0%
1Y
47.1%
C4 Therapeutics
Market Cap: US$109.4m
A clinical-stage biopharmaceutical company, develops novel therapeutic candidates to degrade disease-causing proteins.
CCCC
US$1.48
7D
-1.3%
1Y
-74.3%
Lexeo Therapeutics
Market Cap: US$109.2m
A clinical stage genetic medicine company, focuses on hereditary and acquired diseases with high unmet need in the United States.
LXEO
US$3.53
7D
24.7%
1Y
-76.5%
HLS Therapeutics
Market Cap: CA$151.8m
A specialty pharmaceutical company, acquires and commercializes pharmaceutical products for the treatment of psychiatric disorders, central nervous system, and cardiovascular disease in Canada, the United States, and internationally.
HLS
CA$4.78
7D
2.1%
1Y
22.6%
iCAD
Market Cap: US$108.2m
Provides AI-powered cancer detection solutions in the United States.
ICAD
US$3.96
7D
0.8%
1Y
142.9%
Cibus
Market Cap: US$107.3m
An agricultural biotechnology company, develops and licenses gene edited plant traits using gene editing technologies to enhance farming productivity or produce renewable low carbon plant products.
CBUS
US$2.83
7D
22.3%
1Y
-82.5%
Assembly Biosciences
Market Cap: US$105.4m
A biotechnology company, develops therapeutic candidates for the treatment of viral diseases worldwide.
ASMB
US$14.47
7D
17.3%
1Y
-4.6%
Kewaunee Scientific
Market Cap: US$105.3m
Designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products.
KEQU
US$36.89
7D
-1.6%
1Y
-12.5%
ALT5 Sigma
Market Cap: US$104.8m
Provides blockchain-powered technologies worldwide.
ALTS
US$6.79
7D
2.6%
1Y
102.7%
Entasis Therapeutics Holdings
Market Cap: US$104.8m
Entasis Therapeutics Holdings Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of antibacterial products to treat serious infections caused by multidrug-resistant pathogens in the United States.
ETTX
US$2.19
7D
0%
1Y
-14.8%
Agenus
Market Cap: US$103.9m
A clinical-stage biotechnology company, discovers and develops therapies to activate the body's immune system against cancer and infections in the United States and internationally.
AGEN
US$3.84
7D
13.6%
1Y
-65.5%
Fractyl Health
Market Cap: US$103.8m
A metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity.
GUTS
US$2.10
7D
18.6%
1Y
-71.2%
Ventyx Biosciences
Market Cap: US$103.2m
A clinical-stage biopharmaceutical company, develops oral therapies for patients with autoimmune, inflammatory, and neurodegenerative diseases.
VTYX
US$1.59
7D
32.5%
1Y
-66.5%
MDxHealth
Market Cap: US$102.5m
A commercial-stage precision diagnostics company, provides urologic solutions in the United States, Europe, and internationally.
MDXH
US$2.16
7D
21.3%
1Y
-22.0%
Agape ATP
Market Cap: US$101.5m
An investment holding company, supplies health and wellness products and health solution advisory services in Malaysia.
ATPC
US$2.15
7D
6.4%
1Y
-58.2%
Cardiff Lexington
Market Cap: US$101.1m
Operates in the health care industry in the United States.
CDIX
US$6.50
7D
0%
1Y
-7.1%
Nautilus Biotechnology
Market Cap: US$100.9m
A development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome.
NAUT
US$0.82
7D
-11.3%
1Y
-70.3%
MacroGenics
Market Cap: US$100.3m
A clinical-stage biopharmaceutical company, discovers, develops, manufactures, and commercializes antibody-based therapeutics to treat cancer in the United States.
MGNX
US$1.57
7D
1.9%
1Y
-63.1%
Cassava Sciences
Market Cap: US$100.0m
A clinical stage biotechnology company, develops drugs for neurodegenerative diseases.
SAVA
US$2.24
7D
20.4%
1Y
-89.9%
Coya Therapeutics
Market Cap: US$99.8m
A clinical-stage biotechnology company, develops proprietary therapies to enhance the function of regulatory T cells (Tregs).
COYA
US$5.86
7D
1.7%
1Y
-29.4%
Xtant Medical Holdings
Market Cap: US$99.6m
Provides regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally.
XTNT
US$0.70
7D
17.7%
1Y
-6.8%
Microbot Medical
Market Cap: US$99.4m
A clinical-stage medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space in Israel and the United States.
MBOT
US$2.62
7D
10.1%
1Y
164.6%
Ironwood Pharmaceuticals
Market Cap: US$99.0m
A biotechnology company, focuses on the development and commercialization of therapies for gastrointestinal (GI) and rare diseases in the United States and internationally.
IRWD
US$0.65
7D
-4.6%
1Y
-90.4%
OptiNose
Market Cap: US$98.3m
A specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists.
OPTN
US$9.60
7D
1.6%
1Y
-44.8%
Aroa Biosurgery
Market Cap: AU$151.8m
Develops, manufactures, and sells medical devices for wound and soft tissue repair using extracellular matrix (ECM) technology in the United States and internationally.
ARX
AU$0.44
7D
-2.2%
1Y
-11.1%
Caribou Biosciences
Market Cap: US$97.7m
A clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and autoimmune diseases in the United States and internationally.
CRBU
US$1.10
7D
40.5%
1Y
-64.4%
Cabaletta Bio
Market Cap: US$97.4m
A clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with autoimmune diseases.
CABA
US$1.88
7D
42.4%
1Y
-84.6%
Genelux
Market Cap: US$97.4m
A clinical-stage biopharmaceutical company, focuses on developing oncolytic viral immunotherapies for patients suffering from aggressive and/or difficult-to-treat solid tumor types.
GNLX
US$2.75
7D
10.9%
1Y
-45.2%
HilleVax
Market Cap: US$96.7m
A clinical-stage biopharmaceutical company, develops and commercializes vaccines in the United States.
HLVX
US$2.02
7D
5.2%
1Y
-86.1%
TurnKey Capital
Market Cap: US$96.1m
HealthSpan Medical Systems, Inc. develops marijuana based intravenous therapy (IV) infusion blends for healthcare practitioners.
TKCI
US$0.23
7D
-71.6%
1Y
n/a
Cuprina Holdings (Cayman)
Market Cap: US$96.1m
A biomedical and biotechnology company, focuses on the development and commercialization of products for the management of chronic wounds.
CUPR
US$4.40
7D
1.6%
1Y
n/a
BioSyent
Market Cap: CA$132.2m
Acquires or licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally.
RX
CA$11.70
7D
8.3%
1Y
30.0%
Corbus Pharmaceuticals Holdings
Market Cap: US$95.0m
A biopharmaceutical company, develops products to defeat serious illness.
CRBP
US$7.57
7D
4.3%
1Y
-83.3%